Dr. Anthony Dimarino, M.D

NPI: 1780643775
Total Payments
$10,356
2023 Payments
$141.28
Companies
11
Transactions
32
Medicare Patients
2,077
Medicare Billing
$251,282

Payment Breakdown by Category

Consulting$5,000 (48.3%)
Other$4,750 (45.9%)
Food & Beverage$591.91 (5.7%)
Education$14.50 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $5,000 1 48.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,750 4 45.9%
Food and Beverage $591.91 26 5.7%
Education $14.50 1 0.1%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $5,000 1 $0 (2021)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $2,750 3 $0 (2021)
Valeant Pharmaceuticals North America LLC $2,000 1 $0 (2017)
FUJIFILM Healthcare Americas Corporation $170.47 2 $0 (2022)
AbbVie Inc. $164.55 11 $0 (2023)
Janssen Biotech, Inc. $113.23 8 $0 (2019)
Laborie Medical Technologies Corp. $64.54 1 $0 (2023)
Celgene Corporation $31.94 2 $0 (2023)
Amgen Inc. $29.55 1 $0 (2022)
Medtronic, Inc. $17.63 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2023 $141.28 6 Laborie Medical Technologies Corp. ($64.54)
2022 $231.84 6 FUJIFILM Healthcare Americas Corporation ($142.97)
2021 $5,804 5 GlaxoSmithKline, LLC. ($5,000)
2020 $14.89 1 AbbVie Inc. ($14.89)
2019 $1,089 7 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($1,000)
2018 $1,056 5 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($1,000)
2017 $2,019 2 Valeant Pharmaceuticals North America LLC ($2,000)

All Payment Transactions

32 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
09/22/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $16.08 General
Category: Neuroscience
09/15/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $15.86 General
Category: Neuroscience
09/12/2023 AbbVie Inc. RINVOQ (Biological) Food and Beverage In-kind items and services $15.28 General
Category: IMMUNOLOGY
08/08/2023 Laborie Medical Technologies Corp. Food and Beverage Cash or cash equivalent $64.54 General
06/14/2023 AbbVie Inc. RINVOQ (Biological) Food and Beverage In-kind items and services $15.40 General
Category: IMMUNOLOGY
01/06/2023 AbbVie Inc. SKYRIZI (Biological) Food and Beverage In-kind items and services $14.12 General
Category: IMMUNOLOGY
12/05/2022 Amgen Inc. AVSOLA (Biological) Food and Beverage In-kind items and services $29.55 General
Category: Inflammation
09/14/2022 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $11.94 General
Category: IMMUNOLOGY
05/21/2022 FUJIFILM Healthcare Americas Corporation FUJIFILM (Device) Food and Beverage In-kind items and services $142.97 General
Category: Medical Device
05/19/2022 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $14.86 General
Category: GASTROENTEROLOGY
02/07/2022 ABBVIE INC. HUMIRA (Biological) Food and Beverage In-kind items and services $14.89 General
Category: IMMUNOLOGY
01/25/2022 Medtronic, Inc. GI GENIUS (Device) Food and Beverage In-kind items and services $17.63 General
Category: Gastrointestinal AI
09/28/2021 FUJIFILM Healthcare Americas Corporation FUJIFILM (Device) Food and Beverage In-kind items and services $27.50 General
Category: Medical Device
08/05/2021 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $5,000.00 General
06/25/2021 AbbVie Inc. CREON (Drug) Food and Beverage In-kind items and services $12.85 General
Category: ENDOCRINOLOGY
06/11/2021 AbbVie Inc. VIBERZI (Drug), LINZESS Food and Beverage In-kind items and services $13.37 General
Category: GASTROENTEROLOGY
03/04/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $750.00 General
Category: Gastroenterology
01/20/2020 AbbVie Inc. CREON (Drug) Food and Beverage In-kind items and services $14.89 General
Category: ENDOCRINOLOGY
06/05/2019 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,000.00 General
Category: GASTROENTEROLOGY
05/15/2019 Janssen Biotech, Inc. STELARA (Biological), SIMPONI Food and Beverage In-kind items and services $19.10 General
Category: Immunology
04/17/2019 Janssen Biotech, Inc. STELARA (Biological), SIMPONI Food and Beverage In-kind items and services $14.66 General
Category: Immunology
03/13/2019 Janssen Biotech, Inc. STELARA (Biological), SIMPONI, REMICADE Food and Beverage In-kind items and services $15.44 General
Category: Immunology
02/25/2019 Janssen Biotech, Inc. STELARA (Biological), SIMPONI Food and Beverage In-kind items and services $10.91 General
Category: Immunology
02/13/2019 Janssen Biotech, Inc. STELARA (Biological), SIMPONI Food and Beverage In-kind items and services $14.56 General
Category: Immunology
01/16/2019 Janssen Biotech, Inc. STELARA (Biological), SIMPONI Food and Beverage In-kind items and services $14.74 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 291 349 $140,239 $31,811
2022 10 573 659 $400,857 $72,813
2021 9 610 721 $418,432 $79,428
2020 11 603 703 $361,903 $67,230
Total Patients
2,077
Total Services
2,432
Medicare Billing
$251,282
Procedure Codes
43

All Medicare Procedures & Services

43 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 90 117 $26,625 $11,034 41.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 74 103 $28,325 $6,469 22.8%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 17 17 $18,230 $3,252 17.8%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 20 20 $24,576 $3,030 12.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 19 19 $5,320 $2,396 45.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 29 30 $5,550 $2,150 38.7%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 26 27 $26,013 $2,097 8.1%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 16 16 $5,600 $1,383 24.7%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 91 91 $110,032 $13,199 12.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 123 174 $40,830 $13,017 31.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 78 109 $24,775 $11,144 45.0%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 46 46 $38,615 $8,974 23.2%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 83 85 $81,979 $7,419 9.0%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 29 29 $38,190 $5,979 15.7%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 43 43 $13,910 $4,387 31.5%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 23 23 $23,800 $3,246 13.6%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 12 12 $10,060 $2,354 23.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 19 19 $3,520 $1,317 37.4%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 14 16 $13,516 $1,297 9.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 12 12 $1,630 $478.76 29.4%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 151 219 $40,515 $16,705 41.2%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 108 108 $130,784 $14,270 10.9%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2021 57 57 $43,430 $11,542 26.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 71 108 $19,790 $11,051 55.8%
45385 Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare Facility 2021 38 39 $51,540 $8,637 16.8%

About Dr. Anthony Dimarino, M.D

Dr. Anthony Dimarino, M.D is a Gastroenterology healthcare provider based in Phila, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780643775.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Dimarino, M.D has received a total of $10,356 in payments from pharmaceutical and medical device companies, with $141.28 received in 2023. These payments were reported across 32 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($5,000).

As a Medicare-enrolled provider, Dimarino has provided services to 2,077 Medicare beneficiaries, totaling 2,432 services with total Medicare billing of $251,282. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Phila, PA
  • Active Since 03/20/2006
  • Last Updated 12/06/2007
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1780643775

Products in Payments

  • XIFAXAN (Drug) $4,750
  • FUJIFILM (Device) $170.47
  • STELARA (Biological) $113.23
  • Mavyret (Drug) $36.95
  • ZEPOSIA (Drug) $31.94
  • RINVOQ (Biological) $30.68
  • AVSOLA (Biological) $29.55
  • CREON (Drug) $27.74
  • SKYRIZI (Biological) $26.06
  • GI GENIUS (Device) $17.63
  • HUMIRA (Biological) $14.89
  • LINZESS (Drug) $14.86
  • Kanuma (Drug) $14.50
  • VIBERZI (Drug) $13.37

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Phila